Risk assessment of maternally inherited <i>SDHD</i> paraganglioma and phaeochromocytoma
Nelly Burnichon(Inserm), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Nelly Wion(Centre Hospitalier Universitaire de Grenoble), Judith Favier(Inserm), V. Kerlan(Centre Hospitalier Régional Universitaire de Brest), Brigitte Delemer(Centre Hospitalier Universitaire de Reims), Antoine Tabarin(Université de Bordeaux), Khadija Lahlou‐Laforêt(Assistance Publique – Hôpitaux de Paris), Laurence Amar(Unit of Functional and Adaptive Biology), Philippe Herman(Université Paris Cité), Isabelle Coupier(Inserm), Delphine Drui, Isabelle Guilhem(Centre National de la Recherche Scientifique), Jean‐Michaël Mazzella(Assistance Publique – Hôpitaux de Paris), Jérôme Bertherat(Centre National de la Recherche Scientifique)
Cited by 55
Related Papers
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
|European Journal of Endocrinology|2016|1.5k
The ratio of the nucleon structure functions F2N for iron and deuterium
|Physics Letters B|1983|1.1k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791